By Scientia Professor Anthony D Kelleher

Book Chapters

Appay V; Sauce D; Kelleher AD, 2019, 'HIV Infection as a Model of Accelerated Immunosenescence', in Handbook of Immunosenescence, Springer International Publishing, pp. 1961 - 1989, http://dx.doi.org/10.1007/978-3-319-99375-1_50

Ognenovska K; Klemm V; Ledger S; Turville S; Symonds G; Kelleher A; Ahlenstiel CL, 2018, 'Mechanisms for Controlling HIV-1 infection: a Gene Therapy Approach', in In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders, http://dx.doi.org/10.5772/intechopen.72962

Appay V; Sauce D; Kelleher A, 2017, 'HIV Infection as a Model of Accelerated Immunosenescence.', in Bachtarzi H (ed.), Handbook of Immunosenescence Basic Understanding and Clinical Implications, http://dx.doi.org/10.1007/978-3-319-64597-1_50-1

Pinto A; Kelleher AD; Cooper DA, 2014, 'AIDS : Clinical Manifestations', in Encyclopaedia of Life Sciences, John Wiley & Sons, http://dx.doi.org/10.1002/9780470015902.a0002237.pub3

Alford J; Kelleher A, 2013, 'The Immunocompromised Patient', in Fulde G; Fulde S (ed.), Emergency Medicine: the Principles of Practice, Churchill Livingston, Sydney, pp. 862 - 889, https://www.elsevier.com/books/emergency-medicine/fulde/978-0-7295-8146-2

Kelleher AD; Cooper DA, 2012, 'Chapter 6 Acute HIV infection', in Sande's HIV/AIDS Medicine, Elsevier, pp. 77 - 88, http://dx.doi.org/10.1016/b978-1-4557-0695-2.00006-7

Kelleher A; Kelly M, 2009, 'Immune Restoration Diseases', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, pp. 287 - 294

Alford J; Kelleher AD, 2009, 'The immunosuppressed patient', in Fulde G (ed.), Emergency Medicine, the Principles of Practice, Elsevier, Australia, pp. 665 - 686, http://shop.mja.com.au/

Alford J; Kelleher A, 2009, 'The immunosuppressed patient', in Emergency Medicine, Elsevier, pp. 665 - 686, http://dx.doi.org/10.1016/b978-0-7295-3876-3.10042-5

Kelleher AD; Cooper DA, 2008, 'Acute HIV Infection', in Volberding PA; Sande MA; Greene WC; Lange JMA (ed.), Global HIV/AIDS Medicine, Elsevier Inc, Philadelphia, PA, pp. 63 - 74

Kelleher AD; Cooper DA, 2008, 'CHAPTER 6 Acute HIV Infection', in Global HIV/AIDS Medicine, Elsevier, pp. 63 - 74, http://dx.doi.org/10.1016/b978-1-4160-2882-6.50010-1

Ramacciotti TP; Kelleher AD; Cooper DA, 2008, 'Infeccion primaria por HIV. [Primary HIV-1 Infection]', in Benettuci JA (ed.), SIDA y Enfermedades Associadas (AIDS and Infectious Diseases), 3a edicion., FUNDAI, Buenos Aires, pp. 155 - 170

Kelleher AD; Cooper DA, 2007, 'Acute HIV Infection', in Global HIV/AIDS Medicine, pp. 63 - 74, http://dx.doi.org/10.1016/B978-1-4160-2882-6.50010-1

Ramacciotti TP; Smith DE; Emery S; Kelleher AD; Cooper DA, 2005, 'Therapeutic vaccination in PHI', in Jenssen H; Jager H (ed.), Primary HIV Infection ? Pathology, Diagnosis, Management, Thieme, Stuttgart, pp. 48 - 63

Kelleher A; Orth D, 1997, 'Early HIV-induced immune depletion', in Stewart GJ (ed.), Managing HIV, Medical Journal of Australia

Stewart GJ; Irvine SS; Scott M; Kelleher A; Marriot D; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1997, 'Strategies in managing HIV', in Stewart GJ (ed.), Managing HIV

Journal articles

Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG, 2024, 'Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic', eBioMedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105415

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Templeton DJ; Zablotska-Manos I; Hoy J; Bloch M; Baker D; Brown G; Grulich A; Bavinton B; Pinto AN; Orth D; Roth N; Moore R; Tee BK; Pell C; McNulty A; Templeton DJ; Doong N; Triffitt K; Koelsch KK; Wilson D; Fairley CK; Emery S; Kelleher A; Cooper DA; Grinsztejn B; Bavinton BR; Prestage GP; Zablotska IB; Grulich AE, 2024, 'Condom Failure Among HIV-Negative Men in Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 28, pp. 3587 - 3595, http://dx.doi.org/10.1007/s10461-024-04431-x

Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001

Wang TT; Hirons A; Doerflinger M; Morris KV; Ledger S; Purcell DFJ; Kelleher AD; Ahlenstiel CL, 2024, 'Current State of Therapeutics for HTLV-1', Viruses, 16, http://dx.doi.org/10.3390/v16101616

Matthews G; Jacoby S; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Bennet JA; Avihingsanon A; Chetchotisakd P; Wagner Cardoso S; Azwa I; Losso M; Brown D; Arlinda D; Hutchinson J; Kelleher A; Cisse M; Dao S; Polizzotto M; Emery S; Law M; Papot E; Karyana M; Lupo S; Solari AM; Grinsztejn B; Wolff M; Andrade-Villanueva J; Mosqueda Gómez JL; Chow TS; Mohapi L; Yunihastuti E; Hadi U; Katu S; Subronto YW; Lane HC; Perelis L, 2024, 'Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D²EFT): an open-label, randomised, phase 3b/4 trial', The Lancet HIV, 11, pp. e436 - e448, http://dx.doi.org/10.1016/S2352-3018(24)00089-4

King JM; Giallonardo FD; Shaik A; McGregor S; Yeung JYK; Sivaruban T; Lee FJ; Cunningham P; Dwyer DE; Nigro SJ; Grulich AE; Kelleher AD, 2024, 'Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP use', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26308

Jensen TO; Murray TA; Grandits GA; Jain MK; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV; Chen P; Dewar RL; Goodman AL; Hatlen TJ; Highbarger HC; Holodniy M; Lallemand P; Laverdure S; Leshnower BG; Looney D; Moschopoulos CD; Mugerwa H; Murray DD; Mylonakis E; Nagy-Agren S; Rehman MT; Rupert A; Stevens R; Turville S; Weintrob A; Wick K; Lundgren J; Ko ER; Sahner D; Tierney J; Vogel SE; Herpin BR; Smolskis MC; McKay LA; Cahill K; Crew P; Sardana R; Raim SS; Hensely L; Lorenzo J; Mock R; Zuckerman J; Atri N; Miller M; Vallee D; Chung L; Kang N; Barrett K; Adam SJ; Read S; Draghia-Akli R; Currier J; Hughes E; Harrigan RH; Amos L; Carlsen A; Carter A; Collins G; Davis B; Denning E; DuChene A; Eckroth K; Engen N; Frase A; Gandits G; Harrison M; Hurlbut N; Kaiser P; Koopmeiners J; Larson G; Meger S; Mistry SS; Murray T; Nelson R; Quan K; Quan SF; Reilly C; Siegel L; Thompson G; Vock D; Walski J; Gelijns AC; Moskowitz AJ; Bagiella E; Moquete E; O'Sullivan K; Marks ME; Accardi E; Kinzel E; Burris S; Bedoya G; Gupta L; Overbey JR; Santos M; Gillinov MA, 2024, 'Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study', The Lancet Microbe, 5, pp. e559 - e569, http://dx.doi.org/10.1016/S2666-5247(24)00015-6

Alagaratnam J; Stöhr W; Hamlyn E; Porter K; Toombs J; Heslegrave A; Zetterberg H; Gisslén M; Underwood J; Schechter M; Kaleebu P; Tambussi G; Kinloch S; Miro JM; Kelleher AD; Babiker A; Frater J; Winston A; Fidler S, 2024, 'Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial', Journal of Virus Eradication, 10, http://dx.doi.org/10.1016/j.jve.2024.100381

Cross GB; O’ Doherty J; Chang CC; Kelleher AD; Paton NI, 2024, 'Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials', Journal of Infectious Diseases, 229, pp. 1229 - 1238, http://dx.doi.org/10.1093/infdis/jiad425

Kitawi R; Ledger S; Kelleher AD; Ahlenstiel CL, 2024, 'Advances in HIV Gene Therapy', International Journal of Molecular Sciences, 25, http://dx.doi.org/10.3390/ijms25052771

Obeng BM; Kelleher AD; Di Giallonardo F, 2024, 'Molecular epidemiology to aid virtual elimination of HIV transmission in Australia', Virus Research, 341, http://dx.doi.org/10.1016/j.virusres.2024.199310

Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848

O'Neill RS; Gardner L; Kelleher A; Pamphlett R; Girgis L; Stoita A, 2024, 'Perplexing case of abdominal pain with eosinophilia and fasciitis', Gut, http://dx.doi.org/10.1136/gutjnl-2024-332580

Kelleher AD; Crowe S; Cunningham A, 2024, 'David Albert Cooper 1949–2018', Historical Records of Australian Science, http://dx.doi.org/10.1071/hr23032

Pathmanandavel K; Le S; Xie S; Alves M; Foley E; Kelleher A; Zaunders J; Carr A; Tong W; Breit S; Sewell W; Kane A, 2024, 'Novel clinical applications of functional assays to measure antigen-specific cellular immunity', Pathology, 56, pp. S27 - S27, http://dx.doi.org/10.1016/j.pathol.2023.12.101

Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker GJ; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck HM; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, 2023, 'Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-36295-5

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907

Loprete J; Richardson R; Bramah V; Comben S; Li T; Beiglari L; O'Neill R; McEwan C; Carr A; Tong W; Campbell D; Wong M; Evans L; Post J; Torda A; Kane A; Kelleher A; Wainstein B; McMullan B; Law M, 2023, 'Delabeling, safety, and impact of β-lactam allergy testing: A systematic review', Journal of Allergy and Clinical Immunology: Global, 2, http://dx.doi.org/10.1016/j.jacig.2023.100160

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton DJ; Zablotska-Manos I; Hoy J; McNulty A; Baker D; Brown G; Grulich A; Bavinton B, 2023, 'Agreements, Behaviour, and Change: Sex Outside the Relationship in Male HIV-negative Partners in HIV Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 27, pp. 3098 - 3108, http://dx.doi.org/10.1007/s10461-023-04030-2

Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A; Lane K; Beitler JR; Serra AL; Garcia I; Almasri E; Fayed M; Hubel K; Harris ES; Middleton EA; Barrios MAG; Mathews KS; Goel NN; Acquah S; Mosier J; Hypes C; Salvagio Campbell E; Khan A; Hough CL; Wilson JG; Levitt JE; Duggal A; Dugar S; Goodwin AJ; Terry C; Chen P; Torbati S; Iyer N; Sandkovsky US; Johnson NJ; Robinson BRH; Matthay MA; Aggarwal NR; Douglas IS; Casey JD; Hache-Marliere M; Georges Youssef J; Nkemdirim W; Leshnower B; Awan O; Pannu S; O'Mahony DS; Manian P; Awori Hayanga JW; Wortmann GW; Tomazini BM; Miller RF; Jensen JU; Murray DD; Bickell NA; Zatakia J; Burris S; Higgs ES; Natarajan V; Dewar RL; Schechner A; Kang N; Arenas-Pinto A; Hudson F; Ginde AA; Self WH; Rogers AJ; Oldmixon CF; Morin H; Sanchez A; Weintrob AC; Cavalcanti AB; Davis-Karim A; Engen N; Denning E; Taylor Thompson B; Gelijns AC; Kan V; Davey VJ; Lundgren JD; Babiker AG; Neaton JD; Lane HC; Tierney J; Vogel SE; McNay LA; Cahill K; Crew P; Sardana R; Segal Raim S; Shaw-Saliba K; Atri N; Miller M; Vallee D; Chung L; Delph Y, 2023, 'Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial', The Lancet Respiratory Medicine, 11, pp. 791 - 803, http://dx.doi.org/10.1016/S2213-2600(23)00147-9

Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C, 2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677

Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825

Cross GB; Sari IP; Kityo C; Lu Q; Pokharkar Y; Moorakonda RB; Thi HN; Do Q; Dalay VB; Gutierrez E; Balanag VM; Castillo RJ; Mugerwa H; Fanusi F; Kwan P; Chew KL; Paton NI; Tumukunde D; Akol J; Quyet D; Nguyen H; Hoang XS; Doan TH; Barcelo M; Veto RGMS; Baliwagan MBR; Balane G; Geronimo A; Flores RR; Ng X; Tan S; Kelleher AD; Chang C, 2023, 'Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial', The Lancet Infectious Diseases, 23, pp. 847 - 855, http://dx.doi.org/10.1016/S1473-3099(23)00067-1

Boyd MAA; Carey Hoppe A; Kelleher AD; Munier CML, 2023, 'T follicular helper cell responses to SARS-CoV-2 vaccination among healthy and immunocompromised adults', Immunology and Cell Biology, 101, pp. 504 - 513, http://dx.doi.org/10.1111/imcb.12635

van Bockel D; Kelleher A, 2023, 'The crossroads: divergent roles of virus-specific CD4⁺ T lymphocytes in determining the outcome for human papillomavirus infection', Immunology and Cell Biology, 101, pp. 525 - 534, http://dx.doi.org/10.1111/imcb.12650

Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545

Duette G; Cronin S; Kelleher AD; Palmer S, 2023, 'Viral competition assay to assess the role of HIV-1 proteins in immune evasion', STAR Protocols, 4, http://dx.doi.org/10.1016/j.xpro.2022.102025

Cook L; Zaunders J; Seddiki N; van Bockel D; Kelleher AD; Munier CML, 2023, 'Parallel analysis of multiple human memory CD4⁺ T-cell subsets within antigen-specific responses using cell proliferation dyes', Immunology and Cell Biology, 101, pp. 171 - 178, http://dx.doi.org/10.1111/imcb.12606

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J; Carey Hoppe A, 2023, 'Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses', American Journal of Hematology, 98, pp. 131 - 139, http://dx.doi.org/10.1002/ajh.26619

Khoo WH; Jackson K; Phetsouphanh C; Zaunders JJ; Alquicira-Hernandez J; Yazar S; Ruiz-Diaz S; Singh M; Dhenni R; Kyaw W; Tea F; Merheb V; Lee FXZ; Burrell R; Howard-Jones A; Koirala A; Zhou L; Yuksel A; Catchpoole DR; Lai CL; Vitagliano TL; Rouet R; Christ D; Tang B; West NP; George S; Gerrard J; Croucher PI; Kelleher AD; Goodnow CG; Sprent JD; Powell JE; Brilot F; Nanan R; Hsu PS; Deenick EK; Britton PN; Phan TG, 2023, 'Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19', Clinical Immunology, 246, http://dx.doi.org/10.1016/j.clim.2022.109209

Rankin K; Hastak P; Wong A; Sasson SC; Beaton B; Yeola A; Warden A; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy', eJHaem, 4, pp. 728 - 732, http://dx.doi.org/10.1002/jha2.724

Lundgren JD; Babiker AG; Sharma S; Grund B; Phillips AN; Matthews G; Kan VL; Aagaard B; Abo I; Alston B; Arenas-Pinto A; Avihingsanon A; Badal-Faesen S; Brites C; Carey C; Casseb J; Clarke A; Collins S; Corbelli GM; Dao S; Denning ET; Emery S; Eriobu N; Florence E; Furrer H; Fätkenheuer G; Gerstoft J; Gisslén M; Goodall K; Henry K; Horban A; Hoy J; Hudson F; Azwa RISR; Kedem E; Kelleher A; Kityo C; Klingman K; Rosa AL; Leturque N; Lifson AR; Losso M; Lutaakome J; Madero JS; Mallon P; Mansinho K; Filali KME; Molina J-M; Murray DD; Nagalingeswaran K; Nozza S; Ormaasen V; Paredes R; Peireira LC; Pillay S; Polizzotto MN; Raben D; Rieger A; Sanchez A; Schechter M; Sedlacek D; Staub T; Touloumi G; Turner M; Madruga JV; Vjecha M; Wolff M; Wood R; Zilmer K; Lane HC; Neaton JD; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group , 2023, 'Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.', NEJM Evid, 2, http://dx.doi.org/10.1056/evidoa2200302

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1032911

Back to profile page